P

Inventor

JACOBY EDGAR

BE13 patents
⚠️ This page may combine multiple inventors who share the name “JACOBY EDGAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN PHARMACEUTICA NV

7 patents
US11053248B2Jul 6, 2021

[1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitors

JANSSEN PHARMACEUTICA NV0 citations59
US11236084B2Feb 1, 2022

Substituted azaindoline derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US11186589B2Nov 30, 2021

Cyanoindoline derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US11180487B2Nov 23, 2021

Substituted cyanoindoline derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US11136311B2Oct 5, 2021

Heteroaromatic derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US11001569B2May 11, 2021

6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors

JANSSEN PHARMACEUTICA NV0 citations50
US10947242B2Mar 16, 2021

[1,2,4]triazolo[1,5and#8208;A]pyrimidine compounds as PDE2 inhibitors

JANSSEN PHARMACEUTICA NV0 citations46

JANSSEN SCIENCES IRELAND UNLIMITED CO

2 patents
US11491148B2Nov 8, 2022

Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases

JANSSEN SCIENCES IRELAND UNLIMITED CO0 citations47
US11096931B2Aug 24, 2021

Amide derivatives useful in the treatment of HBV infection or HBV-induced diseases

JANSSEN SCIENCES IRELAND UNLIMITED CO0 citations43

BERGHAUSEN JOERG

1 patent
US8440693B2May 14, 2013

Substituted isoquinolinones and quinazolinones

BERGHAUSEN JOERG14 citations80

BREITENSTEIN WERNER

1 patent
US8163773B2Apr 24, 2012

Organic compounds

BREITENSTEIN WERNER6 citations69

NOVARTIS AG

1 patent
US9051279B2Jun 9, 2015

Substituted isoquinolinones and quinazolinones

NOVARTIS AG1 citations49

JACOBY EDGAR

1 patent
US9649314B2May 16, 2017

Pyrimido[4,5-b]quinoline-4,5(3H,10H)-diones

JACOBY EDGAR0 citations31